Tabula Rasa HealthCare

Tabula Rasa HealthCare Revenue

Delisted

The The revenue of Tabula Rasa HealthCare (TRHC) as of Nov 22, 2026 is 299.52 M USD. In the previous year, The revenue was 331.26 M USD — a change of -9.58% (lower).

Revenue

299.52 MUSD

YoY

-9.58%

Last updated:

In 2022, Tabula Rasa HealthCare's sales reached 299.52 M USD, a -9.58% difference from the 331.26 M USD sales recorded in the previous year.

Revenue has compounded at 31.7% per year over the past 9 years to 299.52 M USD.

The Tabula Rasa HealthCare Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
Date
Revenue
Jan 1, 2019
284.71 M USD
Jan 1, 2020
297.22 M USD
Jan 1, 2021
331.26 M USD
Jan 1, 2022
299.52 M USD
Jan 1, 2023 (e)
362.20 M USD
Jan 1, 2024 (e)
416.43 M USD
Jan 1, 2025 (e)
468.89 M USD
Jan 1, 2026 (e)
403.19 M USD
The Tabula Rasa HealthCare Revenue history
YEARRevenueYoY
est403.19 MUSD-14.01%
est468.89 MUSD+12.60%
est416.43 MUSD+14.97%
est362.20 MUSD+20.93%
299.52 MUSD-9.58%
331.26 MUSD+11.45%
297.22 MUSD+4.39%
284.71 MUSD+39.38%
204.27 MUSD+51.82%
134.55 MUSD+43.04%
94.06 MUSD+34.30%
70.04 MUSD+44.63%
48.43 MUSD+92.61%
25.14 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tabula Rasa HealthCare Revenue

Tabula Rasa HealthCare Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
284.71 M USD
-28.83 M USD
-32.44 M USD
Jan 1, 2020
297.22 M USD
-57.74 M USD
-80.97 M USD
Jan 1, 2021
331.26 M USD
-69.32 M USD
-79.06 M USD
Jan 1, 2022
299.52 M USD
-67.91 M USD
-77.33 M USD
Jan 1, 2023 (e)
362.20 M USD
-27.95 M USD
-971,740.00 USD
Jan 1, 2024 (e)
416.43 M USD
-23.36 M USD
6.07 M USD
Jan 1, 2025 (e)
468.89 M USD
-65.12 M USD
-6.56 M USD
Jan 1, 2026 (e)
403.19 M USD
-6.61 M USD
4,285.69 USD

Tabula Rasa HealthCare Margins

Tabula Rasa HealthCare stock margins

The Tabula Rasa HealthCare margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Tabula Rasa HealthCare. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Tabula Rasa HealthCare.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
36.30 %
-10.13 %
-11.39 %
Jan 1, 2020
31.09 %
-19.43 %
-27.24 %
Jan 1, 2021
29.56 %
-20.93 %
-23.86 %
Jan 1, 2022
22.34 %
-22.67 %
-25.82 %
Jan 1, 2023 (e)
22.34 %
-7.72 %
-0.27 %
Jan 1, 2024 (e)
22.34 %
-5.61 %
1.46 %
Jan 1, 2025 (e)
22.34 %
-13.89 %
-1.40 %
Jan 1, 2026 (e)
22.34 %
-1.64 %
0.00 %

Tabula Rasa HealthCare Stock analysis

What does Tabula Rasa HealthCare do? Tabula Rasa HealthCare Inc is a US-based company specializing in the development of innovative healthcare solutions. The company was founded in 2009 by CEO and Chairman Calvin H. Knowlton and is headquartered in Moorestown, New Jersey. The business model of Tabula Rasa Healthcare offers a wide range of technology solutions focused on improving clinical processes and patient safety. These technology solutions are incorporated into its medication management programs and include electronic medication profiles and clinical decision support systems. By adding SinfoniaRx, Tabula Rasa HealthCare is able to provide a holistic approach to improving medication adherence and compliance. The company offers a broad range of services to enable efficient monitoring of medication effects. Tabula Rasa HealthCare's technology enables personalized medication delivery to ensure that each patient receives the right medication at the right time. Tabula Rasa HealthCare operates in three business divisions: medication safety, medication therapy management, and population health management. In the field of medication safety, the company provides solutions that enable medical personnel to conduct a comprehensive assessment of a patient's medical history and create an accurate medication list. The company also offers support for risk assessment and medication management in patients with multiple or complex chronic conditions. The medication therapy management division covers a range of individual measures aimed at monitoring medication therapies. Tabula Rasa HealthCare's solutions assist healthcare professionals in better understanding patients' medication and improving treatment outcomes. In the population health management field, the company offers tools and strategies for optimizing communicative data analysis to minimize patient requirements and healthcare costs. The company provides technology solutions to revolutionize patient care through the integration of data analytics and a focus on preventive measures. This helps patients achieve better treatment outcomes, detect diseases at an early stage, and save costs. In summary, Tabula Rasa HealthCare Inc is a company focused on developing technology solutions to improve medical decision-making and maximize patient safety. The company utilizes its expertise in various areas and provides customized solutions to ensure personalized and optimized medication delivery. Its business model includes a holistic approach to improving medication adherence and compliance. Tabula Rasa HealthCare is driving medical research and the development of technology solutions to revolutionize modern patient care. Tabula Rasa HealthCare is one of the most popular companies on Eulerpool.

Revenue Details

Understanding Tabula Rasa HealthCare's Sales Figures

The sales figures of Tabula Rasa HealthCare originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Tabula Rasa HealthCare’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Tabula Rasa HealthCare's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Tabula Rasa HealthCare’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Tabula Rasa HealthCare stock

The revenue of Tabula Rasa HealthCare is 299.52 M USD in 2022.

The revenue of Tabula Rasa HealthCare changed from 331.26 M USD to 299.52 M USD, representing a -9.58% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The revenue Tabula Rasa HealthCare since 2006 – with annual values, charts, and detailed analysis.

Revenue is the total value of all goods sold in a period. It is calculated by multiplying the quantity of each product sold by its selling price. Revenue does not include any costs (material costs, personnel costs, etc.), whereas net proceeds only deduct revenue reductions associated with the sale (discounts, etc.).

The revenue's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The revenue's Tabula Rasa HealthCare historically and in real time.

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Tabula Rasa HealthCare

All Key Metrics — Tabula Rasa HealthCare